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Objectives: The aim of this study was to evaluate the psychometric performance of the patient- and parent-reported measures
in the International Consortium for Health Outcomes Measurement (ICHOM) Standard Set for Cleft Care, and to identify ways
of improving concept coverage.
Methods: Data from 714 patients with cleft lip and/or palate, aged 8 to 9, 10 to 12.5, and 22 years were collected between
November 2015 and April 2019 at Erasmus University Medical Center, Boston Children’s Hospital, Duke Children’s Hospital,
and from participating sites in the CLEFT-Q Phase 3 study. The Standard Set includes 9 CLEFT-Q scales, the Nasal Obstruction
Symptom Evaluation (NOSE) questionnaire, the Child Oral Health Impact Profile–Oral Symptoms Scale (COHIP-OSS), and the
Intelligibility in Context Scale (ICS). Targeting, item-fit statistics, thresholds for item responses, and measurement precision
(PSI) were analyzed using Rasch measurement theory.
Results: The proportion of the sample to score within each instruments range of measurement varied from 69% (ICS) to 92%
(CLEFT-Q teeth and COHIP-OSS). Specific problems with individual items within the NOSE and COHIP-OSS questionnaires
were noted, such as poor item fit to the Rasch model and disordered thresholds (6 of 10). Reliability measured with PSI
was above 0.82 for the ICS and all but one CLEFT-Q scale (speech distress). PSIs were lowest for the COHIP-OSS (0.43) and
NOSE questionnaire (0.35).
Conclusion: The patient- and parent-reported components within the facial appearance, psychosocial function, and speech
domains are valid measures; however, the facial function and oral health domains are not sufficiently covered by the
CLEFT-Q eating and drinking, NOSE, and COHIP-OSS, and these questionnaires may not be accurate enough to stratify
cleft-related outcomes.
Keywords: cleft lip and palate, ICHOM, patient-reported outcomes, psychometric performance, Rasch measurement theory.
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Cleft lip and/or palate (CL/P) is the most prevalent congenital
craniofacial anomaly affecting approximately 7.94 per 10 000 live
births worldwide.1,2 This complex disorder can negatively influ-
ence an individuals’ appearance and psychosocial well-being, and
cause functional disabilities such as problems with feeding,
dentition, hearing, and speech.3,4 Patients may need to undergo
many surgical and nonsurgical procedures from infancy through
young adulthood to improve physical and psychosocial function
and well-being. To date, almost every cleft center has its own
treatment protocol based on various literature and own experi-
ences, resulting in differences in outcomes and quality of care.5,6
Research into the psychosocial consequences of different15 - see front matter Copyright ª 2020, ISPOR–The Professional Society for
cess article under the CC BY-NC-ND license (http://creativecommons.org/lictreatment strategies for CL/P has been conducted without a uni-
form strategy.7
Traditionally, the success or failure of a cleft treatment has
been evaluated and interpreted by clinicians6,8,9; however,
clinician-reported outcomes fail to encompass the perspective of
patients and their parents or caregivers, especially with regard to
quality of life. In 2016, the Cleft Lip and Palate Working Group of
the International Consortium for Health Outcomes Measurement
(ICHOM) proposed a Standard Set of cleft-specific outcome mea-
sures for the comprehensive appraisal of cleft care. This set has
been implemented over the past few years in several centers
worldwide.10-13 It stresses the importance of the patient’s
perspective by incorporating parent- and patient-reported
outcome measures (PROMs). Specifically, the set includes 9Health Economics and Outcomes Research. Published by Elsevier Inc. This is an
enses/by-nc-nd/4.0/).
2 VALUE IN HEALTH - 2020CLEFT-Q scales,14-16 the Child Oral Health Impact Profile–Oral
Symptoms Scale (COHIP-OSS),17 the Nasal Obstruction Symptom
Evaluation (NOSE) questionnaire,18 and the parent-reported
Intelligibility in Context Scale (ICS).19 These instruments were
chosen to cover core concepts of facial appearance, psychosocial
function, speech, facial function (including eating/drinking and
breathing), and oral health. Each of these conceptual domains
should be assessed using clinically relevant, reliable, and valid
scales to properly inform clinical decision making and to facilitate
future comparative effectiveness research and quality-
improvement projects.
In encouraging the adoption of any standardized outcomes-
assessment framework, it is essential to verify that each of the
included measures is robust enough to accurately and reliably
appraise the corresponding conceptual construct or outcome
domain. To that end, the aim of this study was to evaluate the
psychometric performance of the patient- and parent-reported
outcome measures in the ICHOM Standard Set for Cleft Care,
such that we might gain insight into potential gaps of concept
coverage.Methods
Study Setting
De-identified CL/P outcome data were collected prospectively
in clinical practice between November 2015 and April 2019 at
Erasmus University Medical Center, Duke Children’s Hospital,
Boston Children’s Hospital, and at international centers partici-
pating in the CLEFT-Q phase 3 study (Canada, United States, United
Kingdom) led by researchers of McMaster University. The aim of
the phase 3 study was to measure change in outcomes following 4
specific cleft-related procedures (alveolar bone grafting, second-
ary cleft lip revision, jaw surgery, and rhinoplasty). Research ethics
approvals were obtained at the Institutional Review Board of each
center.
Patient Population
All patients with orofacial clefts were eligible for data collec-
tion. They were all treated by a multidisciplinary cleft team. Cleft
phenotypic categories were specified as follows: cleft lip (CL); cleft
palate (CP); cleft lip and alveolus (CLA); and cleft lip and palate
(CLAP). Outcomes were measured at time points defined by pa-
tient’s age: T8 (range 8-9), T12 (range 10-12.5), and T22 (22 years
or end of treatment, whichever is soonest).10 Outcome data were
collected electronically via home-based computer, an iPad at
clinics, or paper and pencil and stored with REDCap20,21 or
Gemstracker,11 dependent on the site’s preferences (Supplemental
Materials S1). All scales were administered in the native language
of the country where each institution is located using approved
translations of the instruments.
Patient-Reported Outcome Measures
The outcome measures assessed in this study include 9
patient-reported CLEFT-Q scales, the patient-reported COHIP-OSS
and NOSE questionnaire, and the parent-reported ICS.
The CLEFT-Q is a rigorously developed, cleft-specific instru-
ment focusing on 3 major domains: appearance, facial function,
and health-related quality of life.14-16 Each major domain was
further broken down conceptually into subdomains, based on
thematic content analysis of extensive focus groups and semi-
structured interviews.16 The CLEFT-Q face, jaws, teeth, psycho-
logical, school, social, speech function, and speech distress scales
and the CLEFT-Q eating and drinking checklist were adopted aspart of the ICHOM Standard Set. For the assessment of oral health,
the Child Oral Health Impact Profile–Oral Symptoms Scale (COHIP-
OSS) was included. The COHIP-OSS is a subscale of the larger
COHIP, which was developed to measure various outcomes on oral
health in school-aged children with different oral conditions,
including CL/P.17,22
For assessing the quality of life related to nasal breathing, the
Nasal Obstructive Symptom Evaluation (NOSE) questionnaire was
adopted.18,23 This questionnaire was developed to evaluate
breathing outcomes of rhinoplasty and/or septoplasty treatment
in adults.24
For speech, the Intelligibility in Context Scale (ICS) was
developed to discriminate children with speech difficulties.19
Because parents and family play an important role in represent-
ing the young patient with cleft, they were invited to complete the
ICS by rating the degree of their children's intelligibility when
speaking to various communication partners.
More information on the scales, including the core concepts
measured, timing for completion, and example questions can be
found in Table 1.
Statistical Analysis
Descriptive analyses were performed using SPSS software (IBM
SPSS Statistics for Windows, Version 25.0, released 2017, IBM
Corp). To provide insights into the performances of the PROMs, we
applied Rasch measurement theory using RUMM 2030 software
(RUMM version 2030, 1997-2020, RUMM Laboratory Pty Ltd) to
our dataset with polytomous response options. Rasch analysis is a
method that examines the extent to which the patient’s responses
match the predictions of the responses from the mathematical,
logistic Rasch model. The difference between the expected and
observed responses indicate the degree of rigorous measure-
ment.25-29 Within RUMM, we used the Partial-Credit Model, as
this places no constraints on the threshold parameters. For this
study, the following 4 keystones of Rasch measurement theory
were assessed:Targeting
The extent to which the distribution of the responses of the
sample matches the range that can be measured by a specific scale
is called targeting. Targeting is evaluated both graphically as with
the percentage of the sample to score within the scale’s range.
When the sample is normally distributed and matches the
construct as defined by the sample, a high percentage will be
reached. A lower percentage corresponds with more mismatch
and suggests that some patients’ real ability cannot be determined
with the scale.
Item-fit statistics
To evaluate whether responses are consistent with the ex-
pectations of the Rasch model, 3 fit indicators were examined: the
c2 values (item-trait interaction), the log residuals (item-person
interaction), and the item characteristic curves. The ideal fit re-
siduals are between 22.5 and 12.5 with c2 values nonsignificant
after Bonferroni adjustment. Inconsistent use of response options
or multidimensionality can contribute to individual item misfit.
Thresholds for item response options
The thresholds between the response options of the scales
were examined to determine whether they were used in an
orderly fashion. Disordered thresholds can occur as a consequence
of unclear definitions, too many response options, or underutili-
zation of an option.27
















9 CL, CP, CLA, CLAP 8, 12, 22 How much do you like .
– . how your face looks
when you look your
best?
– . how your face looks
when you smile?




8 CL, CP, CLA, CLAP 8, 12, 22 How much do you like .
– . the size of your teeth?
– . how straight your
teeth look?




7 CL, CP, CLA, CLAP 12, 22 How much do you like .
– . the size of your jaws?
– . how your jaws look
from the side?






10 CL, CP, CLA, CLAP 12 How do you feel?
– I am happy with my life.





10 CL, CP, CLA, CLAP 8, 22 How is your social life?
– I have fun with friends.





10 CL, CP, CLA, CLAP 12 How is your school life?
– I like seeing my friends at
school.




Speech CLEFT-Q speech distress
(patient-reported)
10 CP, CLAP 12, 22 How do you feel about
speaking?
– I get teased about my
speech.





12 CP, CLAP 12, 22 How is your speech?
– It is hard for my family to
understand my speech.





7 CP, CLAP 12 Think about your child’s
speech intelligibility over
the past month and
identify the degree of
understanding.
– Do you understand your
child?
– Do immediate members




Facial function CLEFT-Q eating and
drinking (patient-
reported)
9 CP, CLA, CLAP 8, 12, 22 How is your eating and
drinking?
– Food falls out of my
mouth when I eat.






5 CL, CP, CLA, CLAP 8, 12 How much of a problem
were the following
conditions for you?





















Oral health COHIP-OSS (patient-
reported)
5 CP, CLA, CLAP 8, 12 In the past 3 months, have
you .
– . had pain in your
teeth?
– . had bleeding gums?
Never, almost never,
sometimes, fairly often,
almost all of the time
The measured core concepts including measurement instruments, number of items per scale, phenotypic groups, age groups for scale completion, and examples of
questions with their response options are presented.
CL indicates cleft lip; CLA, cleft lip and alveolus; CLAP, cleft lip and palate; COHIP-OSS, Child Oral Health Impact Profile–Oral Symptoms Scale; CP, cleft palate; ICHOM,
International Consortium for Health Outcomes Measurement; NOSE, Nasal Obstruction Symptom Evaluation.
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For each scale, the estimated measurement precision is given
by the person separation index (PSI). Extreme values were with-
drawn from the analyses. A higher PSI indicates higher reliability
and a better discrimination among patients with different out-
comes. A PSI of 0.7 is the lowest level of acceptability and is able to
differentiate 3 groups.30
Although Rasch measurement theory may also be applied to-
ward the exploration of differences in item functioning between
centers or countries, we did not address differential item func-
tioning (DIF) in this study. For the majority of the scales included
in the Standard Set, DIF has been investigated before; DIF was
examined in the CLEFT-Q international field-test study with 2434
patients from 10 countries. In 23 of the 110 CLEFT-Q items, DIF was
identified by country, but was shown to have negligible impact on
scoring.14Table 2. Patient characteristics.
Characteristics Number of patients (%)
Total N = 714
Cleft type
Cleft lip only 51 (7)
Cleft palate only 165 (23)
Cleft lip and alveolus 73 (10)





Erasmus University Medical Center 362 (51)
Duke Children’s Hospital 105 (15)
Boston Children’s Hospital 95 (13)
CLEFT-Q phase 3 study 152 (21)
Time points Number of measurements (%)
Total N = 748
8 years (range 7-9) 379 (51)
12 years (range 10-13) 244 (32)
22 years (range 20-24) 125 (17)Results
A total of 714 unique patients with CL/P completed at least one
of the scales (as appropriate based on cleft phenotype and age),
resulting in 748 assessments available for analysis. In total, 60%
(n = 425) of patients were found to have CLAP, and 55% (n = 391) of
patients were male. Further demographics are presented in
Table 2.
Results of the Rasch analyses are presented in Table 3. With
regard to targeting, the highest percentages of participants to
score within the scales’ measurement ranges were the CLEFT-Q
teeth and the COHIP-OSS (both 92%). The CLEFT-Q jaws scale
and the ICS were the least targeted (70% and 69%, respectively).
This is depicted in Figure 1, where an example is given of the
person-item threshold distribution for the ICS showing that the
instrument’s items did not cover the ability of persons at the
higher end of the continuum.
Examination of item-fit statistics showed log residuals outside
the 62.5 for 13 of the 102 items for the entire set, from which 6 of
these items had a significant c2 value. These items were all a
marginal source of misfit with minor influence on the validity of
the scale. None of the items in the set failed all 3 criteria for fit. In
Table 4, an example of model fit evaluation with item-
characteristic curves is given for the CLEFT-Q face scale for 2 items.
For thresholds for item response options, 14 of the 102 items
had disordered thresholds, including all 5 items of the COHIP-OSS.
Figure 2 illustrates this phenomenon of disordered thresholds
with a characteristics probability curve of one item of the COHIP-
OSS. The figure shows that the middle response options are never
the most likely to be selected by this population in this specificclinical setting. The NOSE questionnaire and ICS both showed
similar results for one disordered item (“trouble sleeping” and
“understood by parents,” respectively). Rescoring the NOSE
questionnaire and the COHIP-OSS by combining the middle scores
resulted in better threshold ordering. The CLEFT-Q eating and
drinking checklist showed 7 disordered items.
For measurement precision, PSI values ranged from 0.82 to
0.88 for the CLEFT-Q scales, except for the speech distress scale
(0.61) and eating and drinking (0.49). The analysis of the ICS
revealed high reliability with a PSI value of 0.86. In contrast, the
reliability scores for the NOSE and COHIP-OSS questionnaires were
0.35 and 0.43, respectively. This finding suggests that these scales
were therefore not able to discriminate between patients with
different qualities of nasal breathing and oral health.














CLEFT-Q face 695 86 3 1 0 0.86
CLEFT-Q teeth 665 92 2 1 0 0.86
CLEFT-Q jaws 322 70 0 0 0 0.84
CLEFT-Q
psychological
399 77 0 0 0 0.88
CLEFT-Q social 508 81 2 1 0 0.83
CLEFT-Q school 355 81 2 1 0 0.82
CLEFT-Q speech
distress
257 76 0 0 0 0.61
CLEFT-Q speech
function
274 81 1 0 0 0.83
Intelligibility in
Context Scale
210 69 1 0 1 0.86
CLEFT-Q eating
and drinking
501 74 1 1 7 0.49
NOSE 454 72 1 1 1 0.35
COHIP-OSS 426 92 0 0 5 0.43
COHIP-OSS indicates Child Oral Health Impact Profile–Oral Symptoms Scale; NOSE, Nasal Obstruction Symptom Evaluation.
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The ICHOM Cleft Lip and Palate Working Group acknowledged
the importance of the patient perspective of health and included
12 patient- and parent-reported outcome scales in the ICHOM
Standard Set for Cleft Care. These patient- and parent-reported
instruments cover the core concepts of facial appearance, psy-
chosocial function, speech, facial function (including eating/Figure 1. Intelligibility in Context Scale person-item threshold distribu
the histogram in the lower half, and the patient sample, represented
continuum the items are not covered by persons (arrow 1), whereas
persons are not covered by the items (arrow 3). This scale would bendrinking and breathing), and oral health. The instruments were
selected based on multiple criteria, including prior published ev-
idence of instrument validation, clinical significance, practicality
in implementation, availability, and translation into multiple
languages. Although the instruments were previously subject to
some degree of validity testing, they have not yet undergone
robust psychometric evaluation after implementation in real-
world clinical practice. Our study provides the first independenttion. This figure shows the targeting between the items, shown by
by the histogram in the upper half. At the lower end of the
at 15 logit (arrow 2) and at the higher end of the continuum the
efit from including items that are more difficult.
Table 4. Examination of item fit of 2 CLEFT-Q face scale items.
Item Fit
residual
c2 Item-characteristic curve Interpretation
1 22.640 22.34 Marginal overdiscrimination: the observed scores
form a steeper curve than the expected scores. This
item (“how your face looks when you look your best”)
is very similar to another item (“when you are ready
to go out”) and might therefore become redundant;
however, this finding is not significant.
3 2.861* 25.25 Marginal underdiscrimination: the observed scores
form a flatter curve than the expected scores. In
clinical practice, a lot of patients consider this item
(“how much do you like the shape of your face”) as a
more objective item in contrast with the other more
subjective questions in the scale about “how you
look”; however, the deviation is very mild and is not
considered clinically relevant.
The observed values are represented by black dots and the expected values by the curve. High negative fit residuals are associated with redundancy or dependency of
items and high positive fit residuals with multidimensionality.
*Significant P value.
6 VALUE IN HEALTH - 2020evaluation of the psychometric performance of these instruments
as used within the context of the ICHOM Standard Set for Cleft
Care.
The Rasch analysis showed that the scales relating to the
concepts of facial appearance, speech function, and psychosocial
function worked properly with high reliability parameters.Scales That Lacked Adequate Resolution at the Higher
End of the Continuum
The CLEFT-Q speech distress scale, which was incorporated in
the set for the evaluation of 12-year-old children and young-adult
patients with CP or CLAP phenotypes, showed a slightly lower PSI
value than the other CLEFT-Q scales. This is most likely caused by
some mistargeting, because a lot of these patients have already
completed intensive speech therapy and do not experience speech
problems anymore. As a result, reliability of the scale is somewhat
compromised without influencing the other psychometric
characteristics.
The 7-item ICS is included as a parent-reported outcome
measure. It has previously been tested and validated in preschool
aged children without cognitive or developmental disorders and
has shown to be effective in discriminating children with speech
difficulties.19 In our study, the majority of patients scored high. As
a result, a large group of patients is located at the upper extreme
of the continuum, and these patients were not targeted by the
scale items. This miscalibration of the scale range has the effect of
impairing the possibility of accurately determining the patient’s
intelligibility in context, or of being sensitive to change after
speech-related interventions such as revision palatoplasty,pharyngoplasty, or speech therapy. To improve the ICS, more items
are needed at the higher end of the continuum.
Imbalanced Scales That Performed More Like Checklists
Facial function is covered by the CLEFT-Q eating and drinking
checklist and the NOSE questionnaire. The developers of the
CLEFT-Q previously reported that the reliability of the eating and
drinking checklist was low (PSI , 0.60).14 Our present study
confirms these findings: most items in this questionnaire had
disordered thresholds, which is why the creators of the CLEFT-Q
emphasize the use of the term “checklist” rather than “scale.”
Additionally, the NOSE questionnaire asks the patient how
much of a problem some specific symptoms were for the patient
over the past month, for example, “nasal blockage” or “trouble
breathing through my nose.”18,24 This is the first evaluation of
the psychometric properties of the NOSE questionnaire in chil-
dren with CL/P and revealed disordered thresholds for the item
“trouble sleeping.” Prior assessments in adults corroborate that
this item contributed least in terms of measuring the construct of
the scale.24 Anecdotally, cleft clinicians at Erasmus University
Medical Center experienced that the phrasing of the NOSE
questions was too difficult to understand for children of this
young age; parents were often asked to explain what “obstruc-
tion of the nose” means or whether they have “trouble sleeping.”
According to the category probability curves and item-threshold
distribution, most children with CL/P experienced no problems
breathing through their nose and thus respond at the end of the
scale. Experiencing no problems might be incorrect in these
patients because they do not know otherwise in view of their
congenital nature. A small number of children with severe
Figure 2. Category probability curve for item 3 (crooked teeth) of the COHIP-OSS showing disordered thresholds. The x axis represents
the construct with increasing severity to the right. The y axis shows the probability of choosing the response categories. The middle
categories were never the most likely to be selected. COHIP-OSS indicates Child Oral Health Impact Profile – Oral Symptoms Scale.
-- 7problems will score on the other end, whereas the middle op-
tions are not sensitive enough to measure small differences be-
tween patients. This finding was underlined by a very low PSI
indicating no more than 2 groups can be discriminated with this
questionnaire. A similar situation can be seen in a recent appli-
cation of a modified NOSE questionnaire to investigate the
prevalence of nasal obstruction symptoms in children with CL/
P.31 Modifications included a longer recall period of 12 months
and questions and answers being rephrased from “problems” to
“concerns.” For the analysis of frequencies of NOSE scores and
differences between cleft phenotypes, response categories were
merged from 5 to 3. With these response options, differences in
nasal obstruction severity between unilateral and bilateral CLAP
patients were found. This shows that with a small modification
of the NOSE questionnaire, discriminative value can be slightly
increased to enhance clinical utility. Although this instrument
might be useful as a screening tool or symptom checklist in
clinical practice, we believe that the NOSE questionnaire in its
current form is not sufficient as a pediatric PROM scale and
suboptimal for the assessment of the young patient with cleft. In
the same manner that the CLEFT-Q eating and drinking checklist
is called a checklist rather than a scale, we would encourage that
people refer to NOSE as a checklist rather than as a validated
scale, as used in the pediatric cleft population.
This phenomenon of performing as a symptom screening
tool, rather than a robust scale, also applies to the use of the
COHIP-OSS for the assessment of oral health. This instrument
measures the patient’s view on oral health symptoms and was
originally validated in a very heterogeneous sample of patients
with diverse conditions affecting oral health, including patients
with CL/P.17,22 In our analysis of 8- and 12-year-old children with
CL/P, the COHIP-OSS scale demonstrated low reliability, and all
category thresholds were disordered. Most of the children
responded at one end of the scale, reporting they “never” had
any of the symptoms, except for the item “crooked teeth,” which
is most often scored as “almost all of the time.” The latter can be
explained by the fact that 8-year-old children are in mixed
dentition, and orthodontic treatment is awaiting. The middle
response options of the COHIP-OSS were hardly used. Our find-
ings suggest that either there are too many irrelevant response
options, or the 5 options are not distinctive enough. Althoughthis scale has been tested and validated in school-aged children
with different types of clefts, our study confirmed the necessity
to test and validate measurement instruments when used in
different populations and under altered circumstances, because
measurement characteristics can differ.32
To Keep or to Discard? That Is the Question
With regard to the use of PROM data for future comparative
effectiveness research, it is important to minimize measurement
error on outcomes. Therefore, it should be taken into consider-
ation whether the use of poorly validated, not well-understood
instruments for children with CL/P, is sufficient enough for
measuring the respective outcome domains. In a truly valid scale,
all items should measure the same construct, resulting in a sum
score that informs patients and healthcare professionals on the
overall well-being of the patient regarding the specific construct
measured by the scale. The final sum score of a scale can then be
used for comparative effectiveness research. When a scale mea-
sures subtly different constructs, resulting in a checklist, every
single item may be appraised as an independent entity with a
separate score, but no overall sum score should be calculated. A
checklist can still be relevant for clinical decision making, because
individual elements can be intervened upon; however, because of
its multidimensionality it is less suitable for outcome compari-
sons, such as comparing treatment techniques, protocols, or cen-
ters, as sum scores are not interpretable.33,34
An attempt to improve the performances of the CLEFT-Q
eating and drinking checklist, COHIP-OSS questionnaire, and
NOSE questionnaire by adding items or changing response op-
tions could be an option. On the other hand, it may be better to
search for (or develop) a different scale that truly fits the concept.
If the intended usage of these questionnaires is more akin to a
screening tool than a diagnostic tool, then adding a quantitative
measurement (eg, nasometry measurement for the assessment of
the nasal airway) for the corroboration of poorly scoring children
could be considered. If the intended usage of these questionnaires
is for outcome comparisons, a conservative option is to remove
these 3 checklists from the set. This will reduce burden on pa-
tients and will allow the clinicians to focus on the most useful
PROMs.
8 VALUE IN HEALTH - 2020Strengths and Limitations
Because the ICHOM Standard Set is meant to be measured
worldwide, a strength of this study is the international cohort of
patients with CL/P resulting in a reflection of the cleft population
that is eligible for completing the ICHOM Standard Set; however, a
limitation of our study is that low-income countries were not
represented in this cohort. Additionally, as a result of the clinical
transition phase of implementing the set, some 7-year-old chil-
dren were asked to complete one or more of the outcome ques-
tionnaires, resulting in a slightly broader age range than advised
by the ICHOM Reference Guide (age range 8-9).10 The ages of
eligibility were set at 8, because it is known that children as young
as 8 years are able to report on well-being and psychosocial
health35,36; however, given the small number of 7-year-old chil-
dren included in this study and the large total sample size, we do
not expect to find different results. Furthermore, we believe that
including these patients in our sample gives a good reflection of
daily clinical practice.Conclusions
To improve patient-centered care and to facilitate future
comparative effectiveness research and quality-improvement en-
deavors, it is important to include clinically meaningful and
scientifically sound measurement instruments in an outcome set.
This study found that most of the patient- and parent-reported
components recommended by the ICHOM Standard Set for Cleft
Care are valid tools for assessing cleft-specific outcomes. Impor-
tantly, the CLEFT-Q eating and drinking checklist, the COHIP-OSS,
and NOSE questionnaire were not found to be robust enough for
outcomes comparisons, and instead work like a checklist rather
than a measurement scale. As a result, the concepts of facial
function (including eating/drinking and breathing) and oral health
are not sufficiently covered by the PROMs included in the ICHOM
Standard Set for Cleft Care.Supplemental Material
Supplementary data associated with this article can be found in the
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